PubMed Health⌕ Search

Biomedical subjects

M M Misro

Publications and source records attributed to M M Misro.

28 records · Page 2Linked to original sources

Isolation and characterization of gonadotropin-rich secretory granules from rat: depletion by GnRH and by a high affinity agonist.

Gonadotropin secretory granules were purified from rat pituitary tissue by differential centrifugation followed by a continuous metrizamide density gradient separation procedure. Fractions were characterized by radioimmunoassay, electron microscopy and polyacrylamide gel electrophoresis. The LH granule peak distribution across the gradient was biphasic with peaks at densities 1.287 and 1.275 (g/ml). Samples taken from the leading and trailing regions of the LH peak remigrated to similar positions in a second gradient indicating that the pattern was not an artifact caused by reversible aggregation during the isolation procedure. Reproducible separation of the LH granule peak distribution enabled us to assess the effect of secretagogues. GnRH (2 micrograms/rat) and a metabolically stable GnRH agonist (buserelin; 1 microgram/rat) both caused a 6- to 8-fold increase in serum LH and a corresponding reduction (23-25%) in the amount of LH present in the granules. In both cases the reduction was more pronounced on the granules at the higher (1.287 g/ml) density and the bimodal LH distribution was shifted to lower densities (1.280 and 1.265 g/ml). Granules containing growth hormone and prolactin migrated in the denser (1.322-1.318 g/ml) region of the gradient whereas granules containing thyroid stimulating hormone and follicle stimulating hormone were present close to the LH peak. Electron microscopic inspection of ultrathin (60 nm) sections verified that the fractions enriched in immunoassayable gonadotropins contained predominantly granules. In the less dense (1.20 g/ml) regions, mitochondria and membranous debris were present. Fifteen days after ovariectomy, total granule LH content increased 6- to 7-fold and estrogen supplementation at 5 micrograms/rat, but not 1 microgram/rat, reversed this effect to that of sham-operated animals.

Animals↗

Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.

A new male method of contraception by injecting a polymer, styrene-maleic anhydride (SMA), into the lumen of the vas deferens has been studied on rhesus monkeys. The polymer has the dual feature that it can occlude the vas deferens lumen and also it can inhibit the fertilising ability of spermatozoa by virtue of the pH lowering effect. Matings with females were carried out when the lumen was completely occluded giving azoospermia as well as with partial block and spermatozoa present in the semen. All matings were infertile. Data up to one year is presented. All indications are that the contraceptive effect will last for a considerably long period.

Animals↗

An intravasal non-occlusive contraceptive device in rats.

An implantable miniature biogalvanic cell was developed to kill the spermatozoa in the vas deferens by an electric current. Experiments in vitro and in vivo showed that a combination of aluminum/silver electrodes connected with platinum wires with the vas deferens fluid as n electrolyte is effective in killing spermatozoa. Female rats paired with males having biogalvanic devices in the vas deferens, which remained patent, did not produce any young.

Aluminum↗

Endocrinological parameters in experimental unilateral undescended testis.

It is a common clinical practice to estimate FSH, LH and testosterone levels in patients with unilateral undescended testis (U/L UDT) as a prognostic pointer to fertility potential. Is this practice correct? To ascertain this aspect, new born rats were operated to create experimental U/L UDT by gubernaculectomy and anchoring the gubernaculum to anterior abdominal wall. Fertility and hormone levels were evaluated later in adult life. Though fertility of rats with U/L UDT was significantly less (p < 0.01) than the controls, no significant alterations were found in the levels of serum testosterone, FSH and LH. Even though variations in the hormone levels may be responsible, to a certain extent, for the decrease in fertility potential in U/L UDT, estimation of sex hormone levels in U/L UDT is not a sensitive indicator of fertility potential. U/L UDT may additionally be affecting fertility through non-endocrinological mechanisms.

Animals↗

Effect of cyclosporine on human sperm motility in vitro.

Cyclosporine affects motility and viability of human sperm when incubated together in vitro. Sperm motility was almost reduced to nil following 10 min of incubation with cyclosporine at a concentration of 1 mg/mL. However, 200 micrograms/mL of the drug has no effect on motility and viability when tested for up to 60 min under standard laboratory conditions. Cyclosporine effect on sperm was both dose and time dependent. Sperm sensitivity and susceptibility to cyclosporine even to lower doses increased significantly following withdrawal of bovine serum albumin from the incubating medium. Compared to untreated controls, lactate dehydrogenase was estimated higher by more than 2 to 4 times in the sperm-free incubating media, suggesting an altered membrane porosity in the affected spermatozoa.

Cyclosporine↗

GnRH antagonist treatment affects nuclear size and membrane associated indentations in rat Leydig cells.

In semi-thin preparations of rat testis treated with GnRH antagonist (Ac-D2Nal 1, D4ClPhe 2, DTrp 3, DArg 6, DAla 10; GnRH code- 103-289-10, National Institutes of Health, USA) for a period of 5 weeks, Leydig cells showed a reduction of 18% in the mean nuclear area as compared to the controls. The number of cells with nuclear membrane indentations increased by more than 40% as compared to the controls. Nuclear condensation was evident in the form of dark, electron-dense patches of heterochromatin present all along the rough, uneven boundary of the nuclear wall. In some cells, indentations in the nucleus appeared in the form of deep grooves extending into the core of the nucleus. Shrinkage in the cytoplasm of the cells was very much apparent. Circulating levels of LH and testosterone were very low. LH decreased from 29.6 +/- 2.9 ng/ml to 0.55 +/- 0.018 ng/ml and testosterone from 7.8 +/- .29 ng/ml to 0.5 +/- .02 ng/ml. The mean nuclear area of Leydig cells from other groups of rats treated with estradiol 17-beta (1 microgram/rat per day), testosterone (60 micrograms/rat per day) or combinations of testosterone and estradiol or GnRH antagonist and testosterone in the same regime and for the same period remained unaltered. On the other hand, cells appeared normal when testosterone was supplemented (60 micrograms/rat/day) in rats treated with GnRH antagonist. The mean nuclear area of the Leydig cells recovered significantly (p less than 0.001), but was not completely restored.

Animals↗

Adverse effects of chronic GnRH antagonist administration on seminiferous epithelium in adult rats.

Seminiferous epithelium in adult rats was studied by light and electron microscopy after 5 weeks of chronic administration of GnRH antagonist (Ac-D2 Nal 1, D4ClPhe 2, DTrp 3, DArg 6, DAla 10; GnRH code-103-289-10, National Institutes of Health, USA). In these rats, the epithelium showed significant accumulation of vacuoles in more than 80% of the tubules, along with germ cell degeneration and nuclear pyknosis. Disruption in the process of spermatogenesis was also very much evident. In most of the tubules studied (greater than 90%), germ cell development was arrested beyond the pachytene spermatocyte stages. The vacuoles in the seminiferous epithelium were different sizes and when magnified were seen to consist of a thickened outer margin of solid nonfibrous coat within the Sertoli cell cytoplasm. Associated changes in the interstitium showed increased intertubular space but no inflammatory type of response. In actual cell counts, the decrease in the average number of macrophages was 32% and in Leydig cells 23%, while the total number of all types of cells in the interstitium was 30% less than that of the controls. Following the treatment, weights of testis, epididymis, seminal vesicle, and ventral prostate were drastically reduced. Rats treated with testosterone supplementation (60 micrograms/rat day) to GnRH antagonist recovered testicular and epididymal weights to approximately 57% and seminal vesicle and ventral prostate weights by 82.9 and 84%, respectively. Normalcy returned to the tubular epithelium and the interstitial cell counts were restored to original levels.

Animals↗

Roles of FSH and testosterone in the initiation of spermatogenesis in prepubertal rats medically hypophysectomized by a GnRH antagonist.

Experimentally induced medical hypophysectomy in prepubertal rats through treatment of GnRH antagonist for 3 weeks, initiated on the 20th day of age, markedly decreased testicular weight by 85% of that of the controls. Quantitative assessment of spermatogenesis in testicular semithin preparations revealed a significant reduction in the numbers of preleptotene (27.2 +/- 1.6 to 15.6 +/- 0.52) and pachytene (25.8 +/- 0.96 to 5.35 +/- 0.26) spermatocytes and complete absence of any spermatids after the treatment. By contrast, round stage 7 and elongated spermatids were observed in many tubules of the testis in the age-matched control rats. At the end of GnRH antagonist treatment, the blood levels of LH were undetectable, while testosterone and FSH were decreased to 12 and 44% of the controls, respectively. Supplementation of either FSH (ovine FSH 20 micrograms/rat day-1) or testosterone (30 micrograms/rat day-1) enhanced the testicular weight (68%) and the circulatory levels of these hormones, but failed to support quantitatively normal spermatogenesis, which was, however, qualitatively improved. The number of maturing spermatids were comparatively higher in the testosterone-supplemented group that in the FSH-administered group. The latter group had otherwise the highest number of degenerating germ cells per tubule (mean 4.8 +/- 0.1). Testicular weight and stage-specific germ cell counts were restored to normalcy only in rats supplemented with both FSH and testosterone, the critical concentrations of which were important in the initial stages of spermatogenesis. Testosterone alone had a positive effect in terms of germ cell development, while FSH without testosterone was detrimental to the maturing germ cells.

Animals↗